Chris Adams, Author at Pencil Biosciences Limited

Press Release

April 1, 2025

Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have…

Chris Adams

Company News Press Release

April 1, 2025

Pencil Biosciences has secured £5.6m in seed financing for its gene modulation technology that has…

Chris Adams

Company News

September 23, 2023

Pencil Biosciences awarded Innovate UK Investor Partnership grant Pencil Biosciences, a UK-based biotech company, announces…

Chris Adams

Chris Adams